Wells Fargo says that the decline of many healthcare facility stocks in the wake of Trump's victory "is mostly overdone." The firm says that in most cases the declines reflect the repeal of the ACA without any replacement. Howqever, the firm expects the Republicans to pass a new bill that would provide "some coverage" to those who are currently covered under Obamacare. The firm adds that post acute facilities should see "minimal impact" from a repeal of the ACA. It keeps Outperform ratings on Universal Health (UHS), AmSurg (AMSG), and Envision Healthcare (EVHC).
Barclays analyst Andrew Mok raised the firm's price target on Universal Health to $189 from $181 and keeps an Equal Weight rating on the shares post the Q1 report. The company posted broad pricing strength and strong acute inpatient volumes, which drove a big EBITDA beat, the analyst tells investors in a research note.
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSImpinj (PI) up... To see the rest of the story go to thefly.com. See Story Here